Skip to content

EBIT at other companies

Schrodinger logo
SchrodingerSDGR
-$48.79M+4.1%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$128.51M+32.8%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$57.52M+8.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.64M-25.8%
ADMA Biologics logo
ADMA BiologicsADMA
$58.27M+67.1%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's EBIT?
Absci Corporation (ABSI) reported EBIT of -$30.85M in Q1 2026.
How has Absci Corporation's EBIT changed year-over-year?
Absci Corporation's EBIT decreased by 11.2% year-over-year, from -$27.73M to -$30.85M.
What is the long-term trend for Absci Corporation's EBIT?
Over 4 years (2021 to 2025), Absci Corporation's EBIT has grown at a 12.5% compound annual growth rate (CAGR), from -$75.24M to -$120.32M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.